Tregs have a dual role in gynecological cancers. On one hand, they can suppress anti-tumor immune responses, allowing cancer cells to evade detection and grow. On the other hand, their presence has been linked to a better prognosis in some cancers, such as ovarian cancer, where they might help modulate the immune environment favorably. The exact role of Tregs in cancer remains a subject of ongoing research.
